Clinical Trials Directory

Trials / Completed

CompletedNCT02226588

Comparison of Primary and Secondary Prevention of Postpartum Hemorrhage at the Community Level in Egypt

Two Community Strategies Comparing Use of Misoprostol for Secondary Prevention to Primary Prevention for Postpartum Hemorrhage: A Randomized Cluster Non-Inferiority Study in El Beheira Governorate, Egypt

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
2,827 (actual)
Sponsor
Gynuity Health Projects · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

The objective of this study is to compare two community-level strategies: either selective, early administration of 800 mcg sublingual misoprostol to women for secondary prevention of postpartum hemorrhage (PPH) or universal use of 600 mcg oral misoprostol at the time of delivery for prophylaxis of PPH. The significance of this cluster randomized non-inferiority trial is its potential to inform service delivery programs on clinical outcomes, program feasibility, cost, and acceptability of two different community models of PPH care using misoprostol.1. The study hypothesizes that a service delivery model that administers misoprostol for secondary prevention is non-inferior to a model that administers misoprostol for universal prophylaxis.

Conditions

Interventions

TypeNameDescription
DRUGMisoprostol

Timeline

Start date
2014-10-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2014-08-27
Last updated
2016-02-15

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02226588. Inclusion in this directory is not an endorsement.